| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,264 |
957 |
$79K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
414 |
364 |
$31K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
253 |
180 |
$21K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
319 |
245 |
$14K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
540 |
388 |
$7K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
429 |
298 |
$7K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
361 |
278 |
$3K |
| 87428 |
|
31 |
31 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
203 |
123 |
$1K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
14 |
13 |
$439.33 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
21 |
20 |
$229.88 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
31 |
16 |
$26.52 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
40 |
25 |
$25.51 |